CORMEDIX INC. (CRMD)

8.30 -0.12% (-0.01)

Over 5Y: +35.6%

2026-08-28
Style
Area Line Line with markersneeds a shorter window Steps Candlesneeds a shorter window Hollow candlesneeds a shorter window Barsneeds a shorter window

Candles need the day’s open, high and low. Those are being collected now — a company shows them once its history has been refreshed.

5 10 15
2021 2022 2023 2024 2025 2026

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q3 '25 — Revenue: 104.3M Q3 '25 — Operating Cash Flow: 30.9M Q3 '25 — Free Cash Flow: 30.4M Q3 '25 — Net Income: 108.6M Q4 '25 — Revenue: 128.6M Q4 '25 — Operating Cash Flow: 94.5M Q4 '25 — Free Cash Flow: 92.7M Q4 '25 — Net Income: 14M Q1 '26 — Revenue: 127.4M Q1 '26 — Operating Cash Flow: 42.4M Q1 '26 — Free Cash Flow: 41.7M Q1 '26 — Net Income: 38.6M Q2 '26 — Revenue: 101.9M Q2 '26 — Operating Cash Flow: 86.2M Q2 '26 — Free Cash Flow: 85.7M Q2 '26 — Net Income: 26M 0 30M 60M 90M 120M 150M
Q3 '25 Q4 '25 Q1 '26 Q2 '26
Revenue Operating Cash Flow Free Cash Flow Net Income

Figures as at 2026-06-30, reported in USD. The newest fact in the filings is dated 2026-06-30, 61 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

9.4
OE margin 102.1%
Oper. margin 94.6%
Accruals -7.4%
EBITDA margin 103.8%
FCF margin 109.2%
Gross margin 166.8%
OCF margin 110.7%
ROA 20.7%
ROCE 30.3%
ROE 40.6%
OCF / EBIT 1.2×
ROIC —

4 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

1.0
RPO / sales —
RPO growth —
Segment HHI —

3 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

9.0
ND/EBITDA —
Cash / Debt 193.5×
Debt / Eq 0.0029×
Debt payback 0.0 yr
Payout 0.0%
Quick ratio 2.4×
F-score 5.6 pts
Cash runway —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

10.0
Sales CAGR 4Y +319.8%
Sales/sh Y/Y +113.3%
EBIT Y/Y +340.1%
EPS Y/Y +168.1%
Sales Q/Q +312.1%
Shares change +36.4%
Div. growth —
EBIT CAGR —
EPS CAGR 4Y —
EPS next Y —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.